ORAMED PHARMACEUTICALS INC. Debt Instrument, Face Amount
ORAMED PHARMACEUTICALS INC. (ORMP) had Debt Instrument, Face Amount of $101.88 million as of 2023-09-21, per its 10-K filed 2024-03-06.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2024-03-06
- 2023-09-21: Debt Instrument, Face Amount $101.88M.
- 2023-08-08: Debt Instrument, Face Amount $99.55M.
- 2023-06-30: Debt Instrument, Face Amount $2.55M.
- 2023-03-31: Debt Instrument, Face Amount $2.21M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2023-09-21 | $101.88M 10-K · filed 2024-03-06 |
| 2023-08-08 | $99.55M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.55M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $2.21M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.21M 10-K · filed 2023-03-06 |
| 2022-09-30 | $2.21M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $2.21M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $2.21M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $2.21M 10-QT · filed 2022-03-30 |
| 2021-11-30 | $2.21M 10-Q · filed 2022-01-11 |
| 2021-08-31 | $2.21M 10-K · filed 2021-11-24 |
| 2021-05-31 | $2.21M 10-Q · filed 2021-07-14 |
| 2021-02-28 | $2.21M 10-Q · filed 2021-04-13 |
| 2020-11-30 | $2.21M 10-Q · filed 2021-01-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |